Home » Topics » BioWorld Science, Immune

BioWorld Science, Immune
RSS

GlaxoSmithKline presents preclinical data for GSK-102

April 4, 2019

Asceniv approved by FDA to treat humoral immunodeficiency disease

April 2, 2019

Nemo stabilizes Tregs

April 2, 2019

Immunic patents IFN-gamma and IL-17 production inhibitors

April 1, 2019

NIAID initiates phase I study of inactivated subunit H5N1 influenza vaccine

March 29, 2019

Positive phase I/II mid-study results reported for ApoGraft

March 28, 2019

Phase II trial of Triplex for CMV complications in HSCT recipients meets primary endpoint

March 27, 2019

European phase III ARTEMIS study of AR-101 meets primary endpoint

March 26, 2019

Gene editing success in blood stem cells

March 25, 2019

Aptevo initiates dosing in phase I study of APVO-210

March 21, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...